| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8756940 | Auris Nasus Larynx | 2006 | 6 Pages |
Abstract
These findings suggest that DCs transfected with EBV-LMP2A recombinant adenovirus can elicit LMP2A-specific CTLs that have a specific killing effect on NPC in vitro and in vivo. The results provide experimental basis for the further immunotherapy of NPC in clinical trails.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jie-Jie Xu, Kun Yao, Chen-Jie Yu, Xi Chen, Mei-Ping Lu, Hua Sun, Bai-Zhou Li, Chuan-Ning Ding, Feng Zhou,